Health Canada
- Status: approved
🇨🇦 continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion in Canada
continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion (continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion) regulatory status in Canada.
Marketing authorisation
continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion in Canada?
Jin Ni is the originator. The local marketing authorisation holder may differ — check the official source linked above.